当前位置: 首页 >> 检索结果
共有 19803 条符合本次的查询结果, 用时 2.3286863 秒

301. Comment on: Eculizumab as a rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two cases.

作者: Marie Robert.;Thomas Barba.;Emmanuel Ledoult.;Idris Boudhabhay.;Eric Hachulla.;Arnaud Hot.
来源: Rheumatology (Oxford). 2026年65卷2期

302. Relationship between spinal lesions related to axial spondyloarthritis and degenerative spinal lesions: 10-year follow-up of the DESIR cohort.

作者: Laura Pina Vegas.;Floris Alexander van Gaalen.;Miranda van Lunteren.;Damien Loeuille.;Caroline Morizot.;Esther Newsum.;Pascal Claudepierre.;Alain Saraux.;Antoine Feydy.;Monique Reijnierse.;Désirée van der Heijde.;Sofia Ramiro.
来源: Rheumatology (Oxford). 2026年65卷1期
This study aimed to investigate the relationship between spinal axial spondyloarthritis (axSpA)-related lesions and degenerative lesions (DLs) over 10 years (10Y).

303. The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease.

作者: Baptiste Quéré.;Amélie Bourhis.;Patrice Hemon.;Jacques-Olivier Pers.;Jean-Baptiste Noury.;Pascale Marcorelles.;Dewi Guellec.;Yves Allenbach.;Kuberaka Mariampillai.;Sarah Leonard-Louis.;Sébastien Sanges.;Thomas Machet.;Quentin Astouati.;Claude-Alain Maurage.;Gaetane Nocturne.;Clovis Adam.;Alain Meyer.;Beatrice Lannes.;Geoffrey Urbanski.;Anne Croue.;Valérie Devauchelle-Pensec.;Arnaud Uguen.;Divi Cornec.
来源: Rheumatology (Oxford). 2026年65卷2期
Several studies reported an association between Sjögren's disease (SjD) and inclusion body myositis (IBM). However, the potential specificities of IBM when associated with SjD have been poorly investigated. Here, we compared the muscular inflammatory infiltrates between IBM patients with or without associated SjD.

304. Greyscale, colour Doppler and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort.

作者: Konstantinos Triantafyllias.;Anna Mandel.;Theodoros Dimitroulas.;Lorenzo Cavagna.;Christian Geber.;Rebecca Hasseli.;Alexandros Palloks.;Andreas Schwarting.
来源: Rheumatology (Oxford). 2026年65卷2期
To evaluate for the first time a combination of novel colour Doppler ultrasound (CDUS), greyscale (GSUS) and oscillometric indices of angiopathy in patients with autoinflammatory syndromes (AIS). Further, to explore the associations between these markers and patient- and disease-related characteristics, as well as traditional cardiovascular (CV) risk factors.

305. Successful limb salvage by Rheocarna® apheresis in refractory digital ulcers associated with systemic sclerosis.

作者: Ayumi Kishioka.;Eiko Hasegawa.;Naoki Sawa.
来源: Rheumatology (Oxford). 2026年65卷2期

306. Comment on: Short and long-term outcomes of patients with pure membranous lupus nephritis compared to patients with proliferative disease: reply.

作者: Fadi Kharouf.;Qixuan Li.;Laura P Whittall Garcia.;Arenn Jauhal.;Dafna D Gladman.;Zahi Touma.
来源: Rheumatology (Oxford). 2026年65卷2期

307. Comment on: Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease.

作者: Yanxia Chen.;Jinlin Liu.
来源: Rheumatology (Oxford). 2026年65卷2期

308. Difficult-to-treat rheumatoid arthritis (D2TRA) and MDR1 gene: towards personalized medicine.

作者: Carlo Perricone.;Marta di Berardino.;Giacomo Cafaro.;Elena Bartoloni.
来源: Rheumatology (Oxford). 2026年65卷2期

309. Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.

作者: Boonyarak Wattanarat.;Chingching Foocharoen.;Anupol Panitchote.
来源: Rheumatology (Oxford). 2026年65卷2期
This study examines clinical predictors of 28-day mortality in critically ill systemic sclerosis (SSc) patients.

310. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet's syndrome.

作者: Sena Fidan.;Sinem Nihal Esatoglu.;Yesim Ozguler.;Serdal Ugurlu.;Emire Seyahi.;Melike Melikoglu.;Izzet Fresko.;Muazzez Cigdem Oba.;Zekayi Kutlubay.;Gulen Hatemi.
来源: Rheumatology (Oxford). 2026年65卷2期
Beneficial results have been reported among patients with familial Mediterranean fever who switched from coated colchicine to compressed colchicine preparations due to inefficacy or intolerance. In this study, we aimed to assess whether this approach is also beneficial in patients with Behçet's syndrome (BS) with mucocutaneous and/or joint involvement who had an inadequate response to or were intolerant of coated colchicine preparations.

311. Work-related physical strain as novel risk factor for the severity of joint inflammation at diagnosis of anti-citrullinated protein antibodies-positive rheumatoid arthritis.

作者: Dennis A Ton.;Bastiaan T van Dijk.;Hanna W van Steenbergen.;Annette H M van der Helm-van Mil.
来源: Rheumatology (Oxford). 2026年65卷2期
Increased work-related physical strain associates with higher subclinical joint inflammation in the RA at-risk phase of clinically suspect arthralgia and with progression to RA. Based on this, we hypothesized that work-related physical strain is also associated with the severity of joint inflammation at RA diagnosis. We studied this in ACPA-positive and ACPA-negative RA separately, because of differences in aetiopathology.

312. Factors influencing vaccination decisions in patients with inflammatory rheumatic and musculoskeletal disease: a qualitative approach.

作者: Anastasia Suslow.;Romy Lauer.;Uta Kiltz.;Chantal Giehl.;Kerstin Hellwig.;Theresa Oganowski.;Thomas Grüter.;Maria Zacharopoulou.;Andreas Stallmach.;Anika Franz.;Ursula Marschall.;Joachim Saam.;Catharina Schumacher.;Stephanie Stock.;Dusan Simic.;Arim Shukri.;Kathrin Schlößler.;Ina Carola Otte.;Horst Christian Vollmar.; .
来源: BMC Rheumatol. 2026年10卷1期11页
Patients with inflammatory rheumatic and musculoskeletal diseases (iRMD) have an increased risk of infections due to immunosuppression and autoimmune disease. While vaccinations are an important preventive strategy, vaccination coverage remains insufficient in Germany. The study aimed to identify barriers and facilitators for vaccination uptake from the perspective of iRMD patients, general practitioners (GPs), and rheumatologists.

313. COPA syndrome spans multiple organs but is defined by STING in the lung.

作者: Anthony K Shum.
来源: Nat Rev Rheumatol. 2026年22卷4期219-220页

314. One mutation, divergent journeys: expanding the clinical spectrum of homozygous SAMHD1 deficiency in childhood.

作者: Hülya Ercan Emreol.;Dilara Ünal.;Deniz Nazire Cagdas Ayvaz.;Yelda Bilginer.;Seza Özen.
来源: Rheumatology (Oxford). 2026年65卷1期
Homozygous loss-of-function mutations in SAMHD1 classically cause Aicardi-Goutières syndrome type 5 (AGS5), characterized by neuroinflammation and intracranial calcifications. Increasing evidence suggests a broader clinical spectrum. We aimed to describe the phenotypic heterogeneity associated with a single homozygous SAMHD1 variant in paediatric patients and to highlight diagnostic and therapeutic implications.

315. Multiple confounders complicate the calculation of myositis risk with SARS-CoV-2 vaccination.

作者: Thomas Khoo.;Vidya Limaye.
来源: Rheumatology (Oxford). 2026年65卷2期

316. Comment on: Comparable 12-month renal response outcomes with medium- vs high-dose starting prednisone in a real-world study of lupus nephritis: reply.

作者: Maria Pappa.;Spyros Katechis.;Antonis Fanouriakis.
来源: Rheumatology (Oxford). 2026年65卷2期

317. Comment on: Comparable 12-month renal response outcomes with medium- vs high-dose starting prednisone in a real-world study of lupus nephritis.

作者: Alí Duarte-García.
来源: Rheumatology (Oxford). 2026年65卷2期

318. Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practice.

作者: Louise Mercer.;Katie Bechman.;James Galloway.
来源: Rheumatology (Oxford). 2026年65卷2期

319. Engineered sialylated IgG1 Fc as a dose-sparing alternative to IVIG.

作者: Sruthi Vijaya Retnakumar.;Jagadeesh Bayry.
来源: Nat Rev Rheumatol. 2026年22卷3期149-150页

320. Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis.

作者: Yiyun Pang.;Lixi Zhang.;Chen Yao.;Shuang Zhou.;Jie Pang.;Lihua Duan.;Juan Meng.;Chen Yu.;Chanyuan Wu.;Chaojun Hu.;Jinzhi Lai.;Yanhong Wang.;Mingwei Tang.;Lin Qiao.;Dong Xu.;Jiuliang Zhao.;Xiaofeng Zeng.;Zhuang Tian.;Mengtao Li.;Qian Wang.
来源: Rheumatology (Oxford). 2026年65卷1期
Cardiac involvement in idiopathic inflammatory myopathies (IIM) is rare but potentially severe. Anti-mitochondrial M2 antibody (AMA-M2) has been implicated in cardiac involvement, but the association remains underexplored. This study aims to evaluate the clinical, pathological and prognostic features of AMA-M2 IIM.
共有 19803 条符合本次的查询结果, 用时 2.3286863 秒